Clinical Trials To Begin For Sona Nanotech’s COVID-19 Rapid Saliva Test

Sona Nanotech Inc. (CSE: SONA) announced after market close last night that it has received the go signal from the research ethics board to proceed with the previously approved clinical trials for its saliva-based COVID-19 rapid antigen test. The trials are expected to begin next week.

The clinical trials will seek to test up to 500 emergency room patients suspected of having COVID-19 in Humber River Hospital in Toronto. This process, which is expected to last four to ten weeks, seeks to determine the clinical performance of the saliva test in comparison to RT-PCR among symptomatic patients.

Should the trials yield successful results, additional analytical validation studies from third-party agencies would be commissioned to support any future regulatory submissions.

Sona Nanotech Inc. last traded at $1.82 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Critical Minerals Are Rerating! | John Passalacqua – First Phosphate

This Isn’t A Gold Rally. It’s A Warning! | Adrian Day

The U.S. Just Put Real Money Behind Critical Minerals | Simon Clarke – American Critical Minerals

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating

COVID-19 related stocks are all the rage this morning, however it appears to be for...

Monday, November 9, 2020, 10:56:07 AM

Sona Nanotech Rejected By FDA For Emergency Use Authorization

The US Food and Drug Administration has rejected Sona Nanotech’s (CSE: SONA) request for an...

Thursday, October 29, 2020, 09:37:07 AM

Sona Nanotech Releases News.. About Planning To Release News

A tumbling share price can make companies do odd things. If you’re Sona Nanotech (CSE:...

Thursday, August 20, 2020, 10:15:59 AM

Market Movers: Sona Nanotech Moves On COVID-19 Antigen Test Validation

Sona Nanotech (CSE: SONA) is one of the largest movers and shakers of the last...

Monday, July 6, 2020, 02:24:37 PM

Sona Nanotech Withdraws Health Canada Application For COVID-19 Test Due To Feedback From Regulator

In what is a major blow to shareholders of Sona Nanotech (CSE: SONA), the company...

Wednesday, November 25, 2020, 02:31:06 PM